The Role of Natural Killer T Cells in Liver Transplantation

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2024 Jan 22

PMID 38250325

Authors

Wenchao Zhao

Mingqian Li

Shifei Song

Yao Zhi

Chen Huan

Guoyue Lv

Affiliations

Soon will be listed here.

Abstract

Natural killer T cells (NKTs) are innate-like lymphocytes that are abundant in the liver and participate in liver immunity. NKT cells express both NK cell and T cell markers, modulate innate and adaptive immune responses. Type I and Type II NKT cells are classified according to the TCR usage, while they recognize lipid antigen in a non-classical major histocompatibility (MHC) molecule CD1d-restricted manner. Once activated, NKT cells can quickly produce cytokines and chemokines to negatively or positively regulate the immune responses, depending on the different NKT subsets. In liver transplantation (LTx), the immune reactions in a series of processes determine the recipients' long-term survival, including ischemia-reperfusion injury, alloresponse, and post-transplant infection. This review provides insight into the research on NKT cells subpopulations in LTx immunity during different processes, and discusses the shortcomings of the current research on NKT cells. Additionally, the CD56-expressing T cells are recognized as a NK-like T cell population, they were also discussed during these processes.

Citing Articles

The spatial impact of a Western diet in enriching Galectin-1-regulated Rho, ECM, and SASP signaling in a novel MASH-HCC mouse model.

Setayesh T, Hu Y, Vaziri F, Wei D, Wan Y Biomark Res. 2024; 12(1):122.

PMID: 39402682 PMC: 11476289. DOI: 10.1186/s40364-024-00660-3.

Mechanisms of Tolerance Induction in Liver Transplantation: Lessons Learned from Fetomaternal Tolerance, Autoimmunity and Tumor Immunity.

Nakano T, Goto S, Chen C Int J Mol Sci. 2024; 25(17).

PMID: 39273280 PMC: 11395488. DOI: 10.3390/ijms25179331.

References

Srivastava R, Aggarwal R, Bhagat M, Chowdhury A, Naik S . Alterations in natural killer cells and natural killer T cells during acute viral hepatitis E. J Viral Hepat. 2008; 15(12):910-6. DOI: 10.1111/j.1365-2893.2008.01036.x. View

Uchida T, Kinoshita M, Fukasawa M, Habu Y, Shinomiya N, Seki S . IL-18 time-dependently modulates Th1/Th2 cytokine production by ligand-activated NKT cells. Eur J Immunol. 2007; 37(4):966-77. DOI: 10.1002/eji.200636465. View

Zimmerman M, Martin A, Yee J, Schiller J, Hong J . Natural Killer T Cells in Liver Ischemia-Reperfusion Injury. J Clin Med. 2017; 6(4). PMC: 5406773. DOI: 10.3390/jcm6040041. View

Osman Y, Kawamura T, Naito T, Takeda K, Van Kaer L, Okumura K . Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide. Eur J Immunol. 2000; 30(7):1919-28. DOI: 10.1002/1521-4141(200007)30:7<1919::AID-IMMU1919>3.0.CO;2-3. View

Correia M, Costa A, Uhrberg M, Cardoso E, Arosa F . IL-15 induces CD8+ T cells to acquire functional NK receptors capable of modulating cytotoxicity and cytokine secretion. Immunobiology. 2010; 216(5):604-12. DOI: 10.1016/j.imbio.2010.09.012. View

Chang W, Kim J, Kim Y, Kim Y, Lee J, Azuma M . Cutting edge: Programmed death-1/programmed death ligand 1 interaction regulates the induction and maintenance of invariant NKT cell anergy. J Immunol. 2008; 181(10):6707-10. DOI: 10.4049/jimmunol.181.10.6707. View

Berzins S, Smyth M, Baxter A . Presumed guilty: natural killer T cell defects and human disease. Nat Rev Immunol. 2011; 11(2):131-42. DOI: 10.1038/nri2904. View

Rauber C, Bartelheimer K, Zhou T, Rupp C, Schnitzler P, Schemmer P . Prevalence of human herpesviruses in biliary fluid and their association with biliary complications after liver transplantation. BMC Gastroenterol. 2019; 19(1):110. PMC: 6598275. DOI: 10.1186/s12876-019-1033-x. View

Macho-Fernandez E, Brigl M . The Extended Family of CD1d-Restricted NKT Cells: Sifting through a Mixed Bag of TCRs, Antigens, and Functions. Front Immunol. 2015; 6:362. PMC: 4517383. DOI: 10.3389/fimmu.2015.00362. View

10.

Santodomingo-Garzon T, Swain M . Role of NKT cells in autoimmune liver disease. Autoimmun Rev. 2011; 10(12):793-800. DOI: 10.1016/j.autrev.2011.06.003. View

11.

Goubier A, Vocanson M, Macari C, Poyet G, Herbelin A, Nicolas J . Invariant NKT cells suppress CD8(+) T-cell-mediated allergic contact dermatitis independently of regulatory CD4(+) T cells. J Invest Dermatol. 2012; 133(4):980-7. DOI: 10.1038/jid.2012.404. View

12.

Hou X, Hao X, Zheng M, Xu C, Wang J, Zhou R . CD205-TLR9-IL-12 axis contributes to CpG-induced oversensitive liver injury in HBsAg transgenic mice by promoting the interaction of NKT cells with Kupffer cells. Cell Mol Immunol. 2016; 14(8):675-684. PMC: 5549602. DOI: 10.1038/cmi.2015.111. View

13.

Fernandez C, Cameron G, Godfrey D, Kent S . Ex-vivo α-galactosylceramide activation of NKT cells in humans and macaques. J Immunol Methods. 2012; 382(1-2):150-9. DOI: 10.1016/j.jim.2012.05.019. View

14.

Robert-Gangneux F, Drogoul A, Rostan O, Piquet-Pellorce C, Cayon J, Lisbonne M . Invariant NKT cells drive hepatic cytokinic microenvironment favoring efficient granuloma formation and early control of Leishmania donovani infection. PLoS One. 2012; 7(3):e33413. PMC: 3310876. DOI: 10.1371/journal.pone.0033413. View

15.

Duwaerts C, Sun E, Cheng C, van Rooijen N, Gregory S . Cross-activating invariant NKT cells and kupffer cells suppress cholestatic liver injury in a mouse model of biliary obstruction. PLoS One. 2013; 8(11):e79702. PMC: 3829879. DOI: 10.1371/journal.pone.0079702. View

16.

Malhi H, Gores G . Cellular and molecular mechanisms of liver injury. Gastroenterology. 2008; 134(6):1641-54. PMC: 2553363. DOI: 10.1053/j.gastro.2008.03.002. View

17.

Kobayashi E, Motoki K, Uchida T, Fukushima H, Koezuka Y . KRN7000, a novel immunomodulator, and its antitumor activities. Oncol Res. 1995; 7(10-11):529-34. View

18.

Velazquez P, Cameron T, Kinjo Y, Nagarajan N, Kronenberg M, Dustin M . Cutting edge: activation by innate cytokines or microbial antigens can cause arrest of natural killer T cell patrolling of liver sinusoids. J Immunol. 2008; 180(4):2024-8. DOI: 10.4049/jimmunol.180.4.2024. View

19.

Zhai Y, Busuttil R, Kupiec-Weglinski J . Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation. Am J Transplant. 2011; 11(8):1563-9. PMC: 3658307. DOI: 10.1111/j.1600-6143.2011.03579.x. View

20.

Kaneko Y, Harada M, Kawano T, Yamashita M, Shibata Y, Gejyo F . Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J Exp Med. 2000; 191(1):105-14. PMC: 2195789. DOI: 10.1084/jem.191.1.105. View